Safety and Pharmacokinetics of Abicipar Pegol Intravitreal Injections in Patients With Neovascular AMD
Clinical trial NCT02859766 · COMPLETED
Trial details
- NCT number
- NCT02859766
- Sponsor
- Allergan
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-12-07
- Primary completion
- 2017-10-20
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.